In 2026, AI will gain traction in life sciences and biopharmaceuticals, but the key to success is AI that goes deep into the ...

Agilent stands out as a focused, well-managed leader in life science instruments, with strong financials and resilience amid global trade headwinds. The Ignite transformation program enhances supply ...

The broad healthcare sector accounts for roughly one-fifth of the U.S. economy and continues to expand. While most attention tends to go to the direct-care segment, the life-sciences industry is an ...

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers. The life sciences tools and services ...

Equities generally moved higher during the fourth quarter of 2025, seemingly fueled by continued optimism around artificial ...

Julie Utterback, CFA, is a Senior Equity Analyst, Healthcare, for Morningstar. She focuses on medical technology and service companies. She covers managed care organizations including UnitedHealth, ...

April 01, 2026 - PRESSADVANTAGE - As life sciences companies expand globally, the need for effective communication ...

Anthropic has acquired AI biotech startup Coefficient Bio for roughly $400 million, according to a person with knowledge of ...

Life sciences is standing on the edge of its most consequential decade. Scientific discovery is advancing at breakneck speed—cell and gene therapies, advanced biologics, precision diagnostics—all ...